Alicia Pérez-Blanco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alicia Pérez-Blanco has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
- Beatriz Domínguez-Gil
Organización Nacional de Trasplantes, Madrid, Spain
4 shared publications - Elisabeth Coll
Organización Nacional de Trasplantes, Madrid, Spain
3 shared publications - Mario Royo-Villanova
Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
3 shared publications - Alejandro Ortín
Donor Transplant Coordination Unit. Service of Intensive Care. Hospital Universitario Virgen de la Arrixaca. Murcia, Spain. Biomedical Research Institute of Murcia Pascual Parrilla-IMIB, 30120 Murcia, Spain
2 shared publications Beatriz Domínguez-Gil
Organización Nacional de Trasplantes, Madrid, Spain
2 shared publications- Eduardo Miñambres
Donor Transplant Coordination Unit, Service of Intensive Care, Hospital Universitario Marqués de Valdecilla-IDIVAL, School of Medicine, Universidad de Cantabria, Santander, Spain
2 shared publications
Latest Publications
- 26 February 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (7) , 1745-1754
Clinical evidence of the absence of brain perfusion during thoraco-abdominal normothermic regional perfusion in donation after circulatory determination of death
- 26 February 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (7) , 1745-1754
Clinical evidence of the absence of brain perfusion during thoraco-abdominal normothermic regional perfusion in donation after circulatory determination of death
- Top Cited PapersOpen Access
- 31 March 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (8) , 1670-1676
A scintigraphic look at the dead donor rule in donation after the circulatory determination of death with the use of normothermic regional perfusion: A single-center interventional trial
- 31 March 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (8) , 1670-1676
Top Cited PapersOpen AccessA scintigraphic look at the dead donor rule in donation after the circulatory determination of death with the use of normothermic regional perfusion: A single-center interventional trial
- Top Cited PapersOpen Access
- 22 February 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (7) , 1526-1539
DCDD heart transplantation with thoraco-abdominal normothermic regional perfusion and static cold storage: The experience in Spain
- 22 February 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (7) , 1526-1539
Top Cited PapersOpen AccessDCDD heart transplantation with thoraco-abdominal normothermic regional perfusion and static cold storage: The experience in Spain
- Open Access
- 12 April 2024
- Published by Frontiers Media SA in Transplant International
- Vol. 37, 12791
Assessing Outcomes of Patients Subject to Intensive Care to Facilitate Organ Donation: A Spanish Multicenter Prospective Study
Intensive Care to facilitate Organ Donation (ICOD) consists of the initiation or continuation of intensive care measures in patients with a devastating brain injury (DBI) in whom curative treatment is deemed futile and death by neurological criteria (DNC) is foreseen, to incorporate organ donation into their end-of-life plans. In this study we evaluate the outcomes of patients subject to ICOD and identify radiological and clinical factors associated with progression to DNC. In this first prospective multicenter study we tested by multivariate regression the association of clinical and radiological severity features with progression to DNC. Of the 194 patients, 144 (74.2%) patients fulfilled DNC after a median of 25 h (95% IQR: 17–44) from ICOD onset. Two patients (1%) shifted from ICOD to curative treatment, both were alive at discharge. Factors associated with progression to DNC included: age below 70 years, clinical score consistent with severe brain injury, instability, intracranial hemorrhage, midline shift ≥5 mm and certain types of brain herniation. Overall 151 (77.8%) patients progressed to organ donation. Based on these results, we conclude that ICOD is a beneficial and efficient practice that can contribute to the pool of deceased donors.
- 12 April 2024
- Published by Frontiers Media SA in Transplant International
- Vol. 37, 12791
Open AccessAssessing Outcomes of Patients Subject to Intensive Care to Facilitate Organ Donation: A Spanish Multicenter Prospective Study
Intensive Care to facilitate Organ Donation (ICOD) consists of the initiation or continuation of intensive care measures in patients with a devastating brain injury (DBI) in whom curative treatment is deemed futile and death by neurological criteria (DNC) is foreseen, to incorporate organ donation into their end-of-life plans. In this study we evaluate the outcomes of patients subject to ICOD and identify radiological and clinical factors associated with progression to DNC. In this first prospective multicenter study we tested by multivariate regression the association of clinical and radiological severity features with progression to DNC. Of the 194 patients, 144 (74.2%) patients fulfilled DNC after a median of 25 h (95% IQR: 17–44) from ICOD onset. Two patients (1%) shifted from ICOD to curative treatment, both were alive at discharge. Factors associated with progression to DNC included: age below 70 years, clinical score consistent with severe brain injury, instability, intracranial hemorrhage, midline shift ≥5 mm and certain types of brain herniation. Overall 151 (77.8%) patients progressed to organ donation. Based on these results, we conclude that ICOD is a beneficial and efficient practice that can contribute to the pool of deceased donors.
- 4 March 2024
- Published by Springer Nature in Intensive Care Medicine
- Vol. 50 (3) , 437-439
Intensive care admission aiming at organ donation. Pro
- 4 March 2024
- Published by Springer Nature in Intensive Care Medicine
- Vol. 50 (3) , 437-439
Intensive care admission aiming at organ donation. Pro
- Open Access
- 29 June 2023
- Published by Springer Nature in Journal of Bioethical Inquiry
- Vol. 20 (3) , 367-378
Uterus Transplantation as a Surgical Innovation
Uterus transplantation (UTx) research has been introduced in several countries, with trials in Sweden and the United States producing successful outcomes. The growing interest in developing UTx trials in other countries, such as Spain, the Netherlands, Japan, and Australia, raises important questions regarding the ethics of surgical innovation research in the field of UTx. This paper examines the current state of UTx in the context of the surgical innovation paradigm and IDEAL framework and discusses the ethical challenges faced by those considering the introduction of new trials. We argue that UTx remains an experimental procedure at a relatively early stage of the IDEAL framework, especially in the context of de novo trials, where protocols are likely to deviate from those used previously and where researchers are likely to have limited experience of UTx. We conclude that countries considering the introduction of UTx trials should build on the strengths of the reported outcomes to consolidate the evidence base and shed light on the uncertainties of the procedure. Authorities responsible for the ethical governance of UTx trials are advised to draw on the ethical framework used in the oversight of surgical innovation.
- 29 June 2023
- Published by Springer Nature in Journal of Bioethical Inquiry
- Vol. 20 (3) , 367-378
Open AccessUterus Transplantation as a Surgical Innovation
Uterus transplantation (UTx) research has been introduced in several countries, with trials in Sweden and the United States producing successful outcomes. The growing interest in developing UTx trials in other countries, such as Spain, the Netherlands, Japan, and Australia, raises important questions regarding the ethics of surgical innovation research in the field of UTx. This paper examines the current state of UTx in the context of the surgical innovation paradigm and IDEAL framework and discusses the ethical challenges faced by those considering the introduction of new trials. We argue that UTx remains an experimental procedure at a relatively early stage of the IDEAL framework, especially in the context of de novo trials, where protocols are likely to deviate from those used previously and where researchers are likely to have limited experience of UTx. We conclude that countries considering the introduction of UTx trials should build on the strengths of the reported outcomes to consolidate the evidence base and shed light on the uncertainties of the procedure. Authorities responsible for the ethical governance of UTx trials are advised to draw on the ethical framework used in the oversight of surgical innovation.
- Open Access
Family bereavement and organ donation in Spain: a mixed method, prospective cohort study protocol
Introduction There is a discrepancy in the literature as to whether authorising or refusing the recovery of organs for transplantation is of direct benefit to families in their subsequent grieving process. This study aims to explore the impact of the family interview to pose the option of posthumous donation and the decision to authorise or refuse organ recovery on the grieving process of potential donors’ relatives. Methods and analysis A protocol for mixed methods, prospective cohort longitudinal study is proposed. Researchers do not randomly assign participants to groups. Instead, participants are considered to belong to one of three groups based on factors related to their experiences at the hospital. In this regard, families in G1, G2 and G3 would be those who authorised organ donation, declined organ donation or were not asked about organ donation, respectively. Their grieving process is monitored at three points in time: 1 month after the patient’s death, when a semistructured interview focused on the lived experience during the donation process is carried out, 3 months and 9 months after the death. At the second and third time points, relatives’ grieving process is assessed using six psychometric tests: State-Trait Anxiety Inventory, Beck Depression Inventory-II, Inventory of Complicated Grief, The Impact of Event Scale: Revised, Posttraumatic Growth Inventory and Connor-Davidson Resilience Scale. Descriptive statistics (means, SDs and frequencies) are computed for each group and time point. Through a series of regression models, differences between groups in the evolution of bereavement are estimated. Additionally, qualitative analyses of the semistructured interviews are conducted using the ATLAS.ti software. Ethics and dissemination This study involves human participants and was approved by Comité Coordinador de Ética de la Investigación Biomédica de Andalucía (CCEIBA) ID:1052-N-21. The results will be disseminated at congresses and ordinary academic forums. Participants gave informed consent to participate in the study before taking part.
Open AccessFamily bereavement and organ donation in Spain: a mixed method, prospective cohort study protocol
Introduction There is a discrepancy in the literature as to whether authorising or refusing the recovery of organs for transplantation is of direct benefit to families in their subsequent grieving process. This study aims to explore the impact of the family interview to pose the option of posthumous donation and the decision to authorise or refuse organ recovery on the grieving process of potential donors’ relatives. Methods and analysis A protocol for mixed methods, prospective cohort longitudinal study is proposed. Researchers do not randomly assign participants to groups. Instead, participants are considered to belong to one of three groups based on factors related to their experiences at the hospital. In this regard, families in G1, G2 and G3 would be those who authorised organ donation, declined organ donation or were not asked about organ donation, respectively. Their grieving process is monitored at three points in time: 1 month after the patient’s death, when a semistructured interview focused on the lived experience during the donation process is carried out, 3 months and 9 months after the death. At the second and third time points, relatives’ grieving process is assessed using six psychometric tests: State-Trait Anxiety Inventory, Beck Depression Inventory-II, Inventory of Complicated Grief, The Impact of Event Scale: Revised, Posttraumatic Growth Inventory and Connor-Davidson Resilience Scale. Descriptive statistics (means, SDs and frequencies) are computed for each group and time point. Through a series of regression models, differences between groups in the evolution of bereavement are estimated. Additionally, qualitative analyses of the semistructured interviews are conducted using the ATLAS.ti software. Ethics and dissemination This study involves human participants and was approved by Comité Coordinador de Ética de la Investigación Biomédica de Andalucía (CCEIBA) ID:1052-N-21. The results will be disseminated at congresses and ordinary academic forums. Participants gave informed consent to participate in the study before taking part.
- 23 September 2021
- Published by Frontiers Media SA in Transplant International
- Vol. 34 (11) , 2112-2121
Access of non‐residents to transplantation of deceased donor organs: practices and strategies in the European setting
Background The access of non-resident patients to the deceased donor waiting list (DDWL) poses different challenges. The European Committee on Organ Transplantation of the Council of Europe (CD-P-TO) has studied this phenomenon in the European setting. Methods A questionnaire was circulated among Council of Europe member states to inquire about the criteria applied for non-residents to access their DDWL. Results Information was compiled from 28 countries. Less than 1% of non-residents received a deceased donor organ. Two countries never allow non-residents to access the DDWL, 4 allow access without restrictions and 22 only under specific conditions. Of those, most give access to non-resident patients already in their jurisdictions who are in a situation of vulnerability (urgent life-threatening conditions). In addition, patients may be given access: i) after assessment by a specific committee (4 countries); ii) within the framework of official cooperation agreements (15 countries); iii) after patients have officially lived in the country for a minimum length of time (8 countries). The ethical and legal implications of these policies are discussed. Conclusions Countries should collect accurate information about residency status of waitlisted patients. Transparent criteria for the access of non-residents to DDWL should be clearly defined at national level.
- 23 September 2021
- Published by Frontiers Media SA in Transplant International
- Vol. 34 (11) , 2112-2121
Access of non‐residents to transplantation of deceased donor organs: practices and strategies in the European setting
Background The access of non-resident patients to the deceased donor waiting list (DDWL) poses different challenges. The European Committee on Organ Transplantation of the Council of Europe (CD-P-TO) has studied this phenomenon in the European setting. Methods A questionnaire was circulated among Council of Europe member states to inquire about the criteria applied for non-residents to access their DDWL. Results Information was compiled from 28 countries. Less than 1% of non-residents received a deceased donor organ. Two countries never allow non-residents to access the DDWL, 4 allow access without restrictions and 22 only under specific conditions. Of those, most give access to non-resident patients already in their jurisdictions who are in a situation of vulnerability (urgent life-threatening conditions). In addition, patients may be given access: i) after assessment by a specific committee (4 countries); ii) within the framework of official cooperation agreements (15 countries); iii) after patients have officially lived in the country for a minimum length of time (8 countries). The ethical and legal implications of these policies are discussed. Conclusions Countries should collect accurate information about residency status of waitlisted patients. Transparent criteria for the access of non-residents to DDWL should be clearly defined at national level.